Northwest Biotherapeutics Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by MALIK NAVID, was filed 30 Apr 2015.
Northwest Biotherapeutics Inc: what insiders have been doing
Every trade that managers of Northwest Biotherapeutics Inc disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector and is based in Bothell, United States. It was founded in 1998. Northwest Biotherapeutics Inc has had no insider filing for more than a year; the last one goes back to 1 December 2023.
Looking back to 2006, when coverage begins, insiders filed 40 purchases and 27 sales. The 10-K for the year ended 31 December 2025 shows 1.4 m USD of revenue and -60.2 m USD of net income.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Since the insiders bought
- -83.8%Entry US$8.25 · Close at T+365 US$1.34
- -83.8%Entry US$8.25 · Close at T+365 US$1.34
- -83.8%Entry US$8.25 · Close at T+365 US$1.34
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 150,000 shares@ US$0.82326.3% of flowCommon StockSEC:0001104659-23-122940:1
- 295,000 shares@ US$0.81951.5% of flowCommon StockSEC:0001104659-23-122940:2
- 125,000 shares@ US$0.835100.0% of flowCommon StockSEC:0001104659-23-122940:0
- 119,355 shares@ US$0.25100.0% of flowCommon StockSEC:0001104659-23-042303:0
- 28,235 shares@ US$21.25100.0% of flowSeries C Convertible Preferred StockSEC:0001104659-22-124667:0
- 526,316 shares@ US$0.1913.5% of flowCommon StockSEC:0001104659-20-011526:0
- 804,146 shares@ US$0.1718.3% of flowRestricted Common Stock, par value $0.001SEC:0001144204-19-003609:0
- 3,558,639 shares@ US$0.1781.7% of flowRestricted Common Stock, par value $0.001SEC:0001144204-19-003609:1
- 650,000 shares@ US$4.00Common Stock, par value $0.001SEC:0001144204-15-040971:0
- 1,118,092 shares@ US$4.22Common Stock, par value $0.001SEC:0001144204-15-040971:1
- 132,404 shares@ US$5.60Common Stock, par value $0.001SEC:0001144204-15-026502:0Canonical exit: 4 Mar 2014 (T+90)
- 3,013 shares@ US$5.60Common Stock, par value $0.001SEC:0001144204-15-026502:1Canonical exit: 30 Oct 2014 (T+90)
- 35,715 shares@ US$5.60Common Stock, par value $0.001SEC:0001144204-15-026505:0Canonical exit: 16 Jan 2013 (T+90)
- 43,602 shares@ US$4.80Common Stock, par value $0.001SEC:0001144204-15-026505:1Canonical exit: 8 Jan 2013 (T+90)
- 10,000 shares@ US$0.001Common Stock, par value $0.001SEC:0001144204-15-026511:0Canonical exit: 17 Mar 2014 (T+90)
- 389,611 sharesCommon stock, par value $0.001 per share ("Common Stock")SEC:0001144204-14-075196:0Canonical exit: 30 May 2014 (T+90)
- 289,531 sharesCommon StockSEC:0001144204-14-075196:3Canonical exit: 30 Jun 2014 (T+90)
- 341,971 sharesCommon StockSEC:0001144204-14-075196:4Canonical exit: 30 Jul 2014 (T+90)
- 385,320 sharesCommon StockSEC:0001144204-14-075196:5Canonical exit: 30 Aug 2014 (T+90)
- 562,500 sharesCommon StockSEC:0001144204-14-075196:6Canonical exit: 28 Sept 2014 (T+90)
- 796,879 sharesCommon StockSEC:0001144204-14-075196:7Canonical exit: 29 Sept 2014 (T+90)
- 550,219 sharesCommon StockSEC:0001144204-14-075196:8Canonical exit: 30 Oct 2014 (T+90)
- 639,108 sharesCommon StockSEC:0001144204-14-075196:10Canonical exit: 30 Nov 2014 (T+90)
- 1,330,057 sharesCommon StockSEC:0001144204-14-075195:1
- 277,199 sharesCommon stock, par value $0.001 per share ("Common Stock")SEC:0001144204-14-075195:0Canonical exit: 1 Mar 2014 (T+90)
25 of 110 declarations
About Northwest Biotherapeutics Inc
Northwest Biotherapeutics Inc is a company focused on developing immunotherapy treatments for cancer. It is listed on the NASDAQ under the ticker symbol NWBO.
